bluebird bio Announces Global Strategic Collaboration with Celgene to Advance Gene Therapy in Oncology

The announced collaboration will focus on applying gene therapy technology to genetically modify autologous T-cells and generate chimeric antigen receptor (CAR) T-cells targeting cancer cells. Full press release is available here.